Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib significantly improved hair loss and lesions in a patient with overlapping autoimmune disorders.

Blocking the enzyme that turns testosterone into DHT can safely and effectively treat enlarged prostate.

The name Janus is fitting for JAK inhibitors as they revolutionize dermatology treatments.

A stronger dual 5α-reductase inhibitor could improve treatment for benign prostatic hyperplasia by further reducing DHT levels.

New indole-based compounds, particularly cemtirestat, show promise as dual-function drugs for diabetic complications.

Dual therapy with specific medications can help manage male urinary symptoms and reduce side effects.

ITK inhibitors may effectively treat alopecia areata.

5α-reductase inhibitors may prevent prostate cancer but could also raise the risk of more severe cancers.

DFMO may help control hair growth and treat cancer.

5α-reductase inhibitors may reduce male fertility and could be used for male contraception.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

New treatments for enlarged prostate are being developed, some of which may be more effective than current medications.

A new drug, dutasteride, is at least as effective as the older drug, finasteride, for treating enlarged prostate and may have additional uses.

CS-891 may effectively treat hair loss by blocking enzymes in hair follicles.

The hydrogel helps heal seawater-immersed wounds by reducing infection and inflammation.

Compounds from Alpinia zerumbet may help with hair regrowth and cancer treatment by targeting PAK1.

LX-38 is a safer drug option for hair loss and prostate issues without hormonal side effects.

LX-38 is a safer drug option for treating prostate issues and hair loss without hormonal side effects.

Smoke water helps rice roots grow longer but reduces root hair growth under low phosphorus.

The Wnt/β-catenin pathway helps tissue regeneration but can also cause fibrosis, and drugs that inhibit this pathway may aid in healing skin and heart tissues.

Dutasteride is more effective than finasteride for hair loss, but more research is needed on safety and dosing.

Collagen VII helps skin heal and stay strong, sirolimus may lower skin cancer risk in kidney transplant patients, high-molecular-mass hyaluronan helps naked mole rats resist cancer, dermal γδ T cells aid in hair growth in rodents, and overexpression of IL-33 in mouse skin causes itchiness, offering a model for studying allergic inflammation treatments.

Ritlecitinib effectively promotes hair regrowth in severe and very severe alopecia areata.

The document concludes that Catalyst software is effective for drug design, identifying potent compounds for various medical conditions.

The new anti-acne treatment HA-P5 effectively reduces acne by targeting two key receptors and avoids an enzyme that can hinder treatment.

Dutasteride effectively treats enlarged prostate, reduces prostate cancer risk, and promotes hair regrowth with few side effects.

Tumor suppressors help control inflammation in cancer and restoring their function could lead to new treatments.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

EGF receptor is crucial for skin health and its inhibitors can cause skin rashes.

Dupilumab can help hair regrowth but may also trigger alopecia areata.